Genzyme and Ablynx form MS pact
Genzyme and Ablynx form MS pact
Sanofi group Genzyme and Belgian biotech Ablynx have formed a pact to investigate the latter’s nanobodies against a target that plays an important role in MS, in the hope of targeting the neurodegeneration linked with the condition.... Read More - http://www.ms-uk.org/technology
MS-UK - http://www.ms-uk.org/